Các bài viết có thể truy cập công khai - Costabel, UlrichTìm hiểu thêm
Không có ở bất kỳ nơi nào: 4
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled …
J Behr, A Prasse, M Kreuter, J Johow, KF Rabe, F Bonella, R Bonnet, ...
The Lancet Respiratory Medicine 9 (5), 476-486, 2021
Các cơ quan ủy nhiệm: Federal Ministry of Education and Research, Germany
Combination therapy: the future of management for idiopathic pulmonary fibrosis?
WA Wuyts, KM Antoniou, K Borensztajn, U Costabel, V Cottin, B Crestani, ...
The lancet Respiratory medicine 2 (11), 933-942, 2014
Các cơ quan ủy nhiệm: Research Foundation (Flanders), National Institute for Health Research, UK
Gastroesophageal reflux disease in idiopathic pulmonary fibrosis: uncertainties and controversies
Z Wang, F Bonella, W Li, EB Boerner, Q Guo, X Kong, X Zhang, ...
Respiration 96 (6), 571-587, 2018
Các cơ quan ủy nhiệm: National Natural Science Foundation of China
IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease
LB Jehn, U Costabel, E Boerner, TE Wessendorf, D Theegarten, C Taube, ...
Immunobiology 227 (5), 152258, 2022
Các cơ quan ủy nhiệm: US National Institutes of Health
Có tại một số nơi: 24
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management
G Raghu, HR Collard, JJ Egan, FJ Martinez, J Behr, KK Brown, TV Colby, ...
American journal of respiratory and critical care medicine 183 (6), 788-824, 2011
Các cơ quan ủy nhiệm: US National Institutes of Health
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis
L Richeldi, RM Du Bois, G Raghu, A Azuma, KK Brown, U Costabel, ...
New England Journal of Medicine 370 (22), 2071-2082, 2014
Các cơ quan ủy nhiệm: National Institute for Health Research, UK
What's in a name? That which we call IPF, by any other name would act the same
AU Wells, KK Brown, KR Flaherty, M Kolb, VJ Thannickal, KM Antoniou, ...
European Respiratory Journal 51 (5), 2018
Các cơ quan ủy nhiệm: US National Institutes of Health, US Department of Veterans Affairs
Pirfenidone safety and adverse event management in idiopathic pulmonary fibrosis
LH Lancaster, JA de Andrade, JD Zibrak, ML Padilla, C Albera, ...
European respiratory review 26 (146), 2017
Các cơ quan ủy nhiệm: US National Institutes of Health
Antacid therapy and disease outcomes in idiopathic pulmonary fibrosis: a pooled analysis
M Kreuter, W Wuyts, E Renzoni, D Koschel, TM Maher, M Kolb, ...
The Lancet Respiratory Medicine 4 (5), 381-389, 2016
Các cơ quan ủy nhiệm: Versus Arthritis, UK, National Institute for Health Research, UK
Phenotypes of organ involvement in sarcoidosis
JC Schupp, S Freitag-Wolf, E Bargagli, V Mihailović-Vučinić, P Rottoli, ...
European Respiratory Journal 51 (1), 2018
Các cơ quan ủy nhiệm: German Research Foundation, Federal Ministry of Education and Research, Germany
Delphi consensus recommendations for a treatment algorithm in pulmonary sarcoidosis
FF Rahaghi, RP Baughman, LA Saketkoo, NJ Sweiss, JB Barney, ...
European Respiratory Review 29 (155), 2020
Các cơ quan ủy nhiệm: US National Institutes of Health
Whole lung lavage therapy for pulmonary alveolar proteinosis: a global survey of current practices and procedures
I Campo, M Luisetti, M Griese, BC Trapnell, F Bonella, J Grutters, ...
Orphanet journal of rare diseases 11, 1-10, 2016
Các cơ quan ủy nhiệm: US National Institutes of Health
Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study
V Cottin, D Koschel, A Günther, C Albera, A Azuma, CM Sköld, ...
ERJ open research 4 (4), 2018
Các cơ quan ủy nhiệm: US Department of Veterans Affairs, National Institute for Health Research, UK
The burden of sarcoidosis symptoms from a patient perspective
M Voortman, CMR Hendriks, MDP Elfferich, F Bonella, J Møller, ...
Lung 197, 155-161, 2019
Các cơ quan ủy nhiệm: Netherlands Organisation for Health Research and Development
Effect of statins on disease-related outcomes in patients with idiopathic pulmonary fibrosis
M Kreuter, F Bonella, TM Maher, U Costabel, P Spagnolo, D Weycker, ...
Thorax 72 (2), 148-153, 2017
Các cơ quan ủy nhiệm: US Department of Veterans Affairs, Canadian Institutes of Health Research …
Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial
JR Seibold, TM Maher, KB Highland, S Assassi, A Azuma, LK Hummers, ...
Annals of the rheumatic diseases 79 (11), 1478-1484, 2020
Các cơ quan ủy nhiệm: US National Institutes of Health
The role of diverse immune cells in sarcoidosis
H Zhang, U Costabel, H Dai
Frontiers in immunology 12, 788502, 2021
Các cơ quan ủy nhiệm: National Natural Science Foundation of China
Idiopathic pulmonary fibrosis is associated with common genetic variants and limited rare variants
AL Peljto, RZ Blumhagen, AD Walts, J Cardwell, J Powers, TJ Corte, ...
American journal of respiratory and critical care medicine 207 (9), 1194-1202, 2023
Các cơ quan ủy nhiệm: US Department of Defense, US National Institutes of Health, US Department of …
A systematically derived exposure assessment instrument for chronic hypersensitivity pneumonitis
H Barnes, J Morisset, P Molyneaux, G Westall, I Glaspole, HR Collard, ...
Chest 157 (6), 1506-1512, 2020
Các cơ quan ủy nhiệm: US National Institutes of Health, National Health and Medical Research …
Smoking-related idiopathic interstitial pneumonia
KR Flaherty, C Fell, MC Aubry, K Brown, T Colby, U Costabel, TJ Franks, ...
European Respiratory Journal 44 (3), 594-602, 2014
Các cơ quan ủy nhiệm: US National Institutes of Health, National Institute for Health Research, UK
Chương trình máy tính sẽ tự động xác định thông tin xuất bản và thông tin về nhà tài trợ